0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Gynaecology & obstetrics

Buy Now

Adjuvant Chemotherapy of Breast Cancer - Papers Presented at the 2nd International Conference on Adjuvant Chemotherapy of Breast Cancer, Kantonsspital St. Gallen, Switzerland, March 1 - 3, 1984 (Paperback, Softcover reprint of the original 1st ed. 1984) Loot Price: R2,959
Discovery Miles 29 590
Adjuvant Chemotherapy of Breast Cancer - Papers Presented at the 2nd International Conference on Adjuvant Chemotherapy of...

Adjuvant Chemotherapy of Breast Cancer - Papers Presented at the 2nd International Conference on Adjuvant Chemotherapy of Breast Cancer, Kantonsspital St. Gallen, Switzerland, March 1 - 3, 1984 (Paperback, Softcover reprint of the original 1st ed. 1984)

Hans-Joerg Senn

Series: Recent Results in Cancer Research, 96

 (sign in to rate)
Loot Price R2,959 Discovery Miles 29 590 | Repayment Terms: R277 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

H.-J. Senn Adjuvant Chemotherapy (ACT) of breast cancer has now emerged as one of the controversial su):>jects in clinical and also experimental oncology. Driven by growing frustration about stagnating cure rates in breast cancer [1,4] and stimulated by elegant demonstration of highly curative effects of adjuvant systemic therapy in animal models [6, 11] and in several childhood neoplasias [15], researchers introduced ACT to the primary treatment of breast cancer with great hope some 15 years ago. After a first wave of isolated "historic" trials with generally limited but in one case remarkable success [5, 9], a second generation of ACT studies was initiated by NSABP investigators and oncology centers in Europe [2, 6, 13]. These trials were well conducted statistically and diagnostically, and all in the early 1970s included a surgical control arm. Early and intermediate beneficial effects on relapse-free survival (RFS) after 2-3 years median observation time then prompted a whole series of ACT studies in breast cancer. These "third-gener ation" studies usually regarded some positive influence of ACT as a given fact, dropping surgical control regimens and comparing different ACT regimens, hopefully in a prospective, randomized way 1984 Fig. 1. The mushrooming of adjuvant studies in breast cancer XII Introduction [reviews in 3, 14]. The "mushrooming" of ACT studies in breast cancer during the last 10 and especially 5 years is demonstrated in Fig. 1, and it gets really cumbersome even for the insider to keep on top of the multitude of sometimes conflicting data.

General

Imprint: Springer-Verlag
Country of origin: Germany
Series: Recent Results in Cancer Research, 96
Release date: December 2011
First published: 1984
Editors: Hans-Joerg Senn
Dimensions: 244 x 170 x 14mm (L x W x T)
Format: Paperback
Pages: 246
Edition: Softcover reprint of the original 1st ed. 1984
ISBN-13: 978-3-642-82359-6
Categories: Books > Medicine > Surgery > General surgery
Books > Medicine > Clinical & internal medicine > Gynaecology & obstetrics > General
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-642-82359-9
Barcode: 9783642823596

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners